Radiodermatitis Market is expected to reach US$ 506.3 million revenue by 2027
Transparency Market Research (TMR) has published a new report titled, ‘Radiodermatitis Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global Radiodermatitis market was valued at US$ 334.2 Mn in 2018 and is projected to expand at a CAGR of 3.3% from 2019 to 2027.
Request Brochure –
- Radiodermatitis, alternatively known as radiation dermatitis, is a condition caused by radiation therapy utilized for cancer treatment.
- Cumulative daily doses of radiation to the treatment field or target site on the body inhibits the normal skin repopulation and weakens the skin integrity at and around the radiation field
- Radiodermatitis may be acute or chronic and encompasses localized erythema, skin shedding (desquamation), hair loss (epilation), fibrosis, necrosis, and other similar conditions
- Radiodermititis may be treated with the following Topical agents – Corticosteroids, hydrophilic creams, topical antibiotics, Oral Medication: Oral corticosteroids, oral analgesics, anti-inflammatory agents, and antibiotics, Dressings: Hydrogel, hydrocolloid, no sting barrier film, honey impregnated gauze, silicone coated dressing, and others (silver dressings and GM-CSF gauze, etc.)
- Asia Pacific dominated the global Radiodermatitis Market in 2018and the trend is anticipated to continue during the forecast period as this region has a significant pool of patients suffering from cancer as well as taking radiation therapy. Moreover, the basic preventive skincare practices such as washing skin with gentle soap and wearing loose clothing tend to be overlooked by the population in emerging countries. This further increases the need for radiation dermatitis care products.
- Latin America is expected to gain market share during the forecast period and it is expected to expand at a high CAGR during the forecast period.
Request COVID Analysis on Radiodermatitis Market –
Rise in cancer cases and lifestyle factors contributing to cancer leading to radiodermatitis and Rise in adverse events during radiation with chemotherapy to Drive Market
- Not all cancers can be treated with a single type of therapy, and thus, a combination of chemotherapy and radiation is often used in situations where the intent is curative and not palliative care. Patients who receive chemotherapy as well as radiation therapy have higher chance of developing radiodermatitis.
- In addition, the rate of certain types of cancers such as breast cancer and head and neck cancer is projected to escalate. This is attributable to faulty lifestyle factors such as obesity for breast cancer, and smoking for head and neck cancers.
- Moreover, the aforementioned cancers are treated with radiation at site. Hence, patients suffering from these cancers are more likely to develop radiation-induced dermatitis. Therefore, the overall spiral in cancer cases coupled with a surge in specific cancers due to faulty lifestyle is likely to propel the radiodermatitis market.
Request Customization on Radiodermatitis Market Report –
Topical Segment to Dominate Market
- Based on product type, the global Radiodermatitis Market has been divided into topical, oral medication and dressing. The topical segment has been bifurcated into Corticosteroids, Hydrophilic Creams and others. The topical segment dominated the global Radiodermatitis Market in 2018and the trend is projected to continue during the forecast period. Topical steroids have shown to inhibit the up-regulation of cytokines in response to radiation. A randomized control trial by Bostrom et al. (2001) tested prophylactic corticosteroid cream and emollient cream versus placebo cream during radiotherapy and for three weeks following the completion of therapy, wherein corticosteroid showed substantial decrease in radiodermatitis.
- Moreover, the consistent formulation upgrades, product launch, and rigorous efforts to reduce severity associated with radiation induced skin damage, fuelled by increasing demand for better and consistent products from end-users across the globe.
Buy Radiodermatitis Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=2157<ype=S
Retail Pharmacy Store segment to be Highly Lucrative Segment
- In terms of distribution channel, the global Radiodermatitis Market has been classified into Hospital Pharmacy, Retail Pharmacy Store and Online Store.
- The Retail Pharmacy Store segment dominated the Radiodermatitis Market as the retail stores are popular in the local community population and often people have a comfort factor in visiting a retail pharmacy which they have been visiting for many years. Also, local products at cheaper prices are readily available at a retail pharmacy store.
- Overall, multichannel approach works well in this market due to the nature of onset of radiodermatitis (can occur during or after radiation therapy).
Asia Pacific to Dominate Global Market
- In terms of region, the global Radiodermatitis Market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific dominated the global Radiodermatitis Market in 2018, followed by Europe.
- Asia Pacific accounted for major share of the global Radiodermatitis Market in 2018, due to consistent innovative product launches and efforts to reduce cost among key players. The cost factor is important due to the population’s economic status with greater number having average disposable income, fuelled by increasing demand for topical agents and dressings from end-users with high unmet medical needs.
- The Radiodermatitis Market in Latin America & MEA is anticipated to expand at a high CAGR from2019 to 2027. This is attributed to the epidemiological shift in the region from communicable diseases to chronic conditions. Rise in faulty lifestyle has led to an increase in cancer cases in the region. This is set to create demand for radiation therapy and subsequently radiation dermatitis care products is fueling market growth.
- The global Radiodermatitis Market is fragmented in terms of number of players. Key players in the global market include 3M & Co., Acelity, BMG Pharma S.r.l., ConvaTec, DermaSciences Inc., Intermed Pharmaceuticals, Molnlycke Health Care, Smith & Nephew plc, Stratpharma AG among others
The global Radiodermatitis Market has been segmented as follows:
Global Radiodermatitis Market, by Product
- Hydrophilic Creams
- Others (topical antibiotics)
- Oral Medication
- Other (oral analgesics, antibiotics, etc.)
- No Sting Barrier Film
- Honey Impregnated Gauze
- Silicone Coated Dressing
- Others (GM-CSF gauze, silver leaf dressing, etc.)
Global Radiodermatitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy Store
- Online Store
Global Radiodermatitis Market, by Geography
- North America
- Asia Pacific
- Rest of APAC
- Rest of Europe
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453